Skip to the page content
Your donations
Passes our checks

The International Genomics Consortium

EIN 86-1024333 · Phoenix, AZ

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthGood78 out of 100GovernanceFair66 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

THE MISSION OF IGC IS TO REVOLUTIONIZE THE TREATMENT AND PREVENTION OF CANCER AND COMPLEX DISEASES BY RIGOROUSLY DEVELOPING AND APPLYING POST-GENOME SCIENCE TO ADVANCES IN HUMAN HEALTH.

Income
$281,106
Spending
$1.3 million
Spent on programs
52%
Reserves
100.9 months of spending
Largest source of income
other income, 61%
Employees
3
Volunteers
0
Highest pay
$673,442, ceo

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Good: 78 out of 100. Higher than 35% of charities in its peer group (medical research, $250k to $1m).

  • Reserves

    35 of 35

    Spendable reserves would cover 100.9 months of spending.

  • Debt

    20 of 20

    It owes 4% of what it owns.

  • Living within its means

    0 of 15

    Spending exceeded income by 376% of income.

  • Income trend

    15 of 15

    Income rose 235% on the year before.

  • Spending floor

    8 of 15

    52% of spending went to programs.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Fair: 66 out of 100. Higher than 37% of charities in its peer group (medical research, $250k to $1m).

  • Independent board

    0 of 25

    0 of 2 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    5 of 5

    Sets its chief executive's pay through independent review and comparison.

  • Independent check of accounts

    6 of 15

    Its accounts were not audited or reviewed by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (1)
  1. $695,649 spent. IGC CONTINUES TO BUILD ON THEIR ONGOING RESEARCH COLLABORATIONS WITH A VARIETY OF HOSPITALS INCLUDING WITH SCOTTSDALE HEALTHCARE HOSPITAL (NOW HONORHEALTH) BY PROVIDING ACCESS TO ITS BANKED SPECIMENS WITH CLINICAL DATA GATHERED IN COLLABORATION WITH THE HEALTH CARE CENTERS. THESE ARE REDISTRIBUTED TO SUPPORT A VARIETY OF RESEARCH INCLUDING THE CANCER GENOME ATLAS PROJECT AT THE NATIONAL CANCER INSTITUTE AND FOLLOW ON STUDIES AND DATA ACCESS QUERIES. IGC'S RESEARCH SERVICES UTILIZES THE CLINICAL TRIALS AND ANALYSIS EXPERTISE AS WELL AS THE DATA COLLECTED FROM THEIR HOSPITAL AND CLINICAL COLLABORATORS TO ACCELERATE AND INCUBATE INNOVATIVE RESEARCH PROGRAMS IN WOMEN'S HEALTH, EARLY CANCER DIAGNOSTICS AND TO FIND NEW PATHWAYS FOR INNOVATIVE TREATMENT METHODS. IGC ALSO REFINES THE DATA FROM THE NATIONAL LUNG SCREENING TRIAL (NLST) AT THE NCI TO LEVERAGE THE DATABASE TO IMPACT CLINICAL UTILITY.IGC COLLABORATES WITH PRECISION FOR MEDICIENE TO PROVIDE ACCESS TO IGC'S EXPO SPECIMENS ACROSS THE MOST PREVALANT CANCER TYPES INCLUDING ASSOCIATED CLINICAL DATA AND ANALYSIS.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since February 2002.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.